Juvenile Arthritis


The Financial Impact of Juvenile Idiopathic Arthritis

October 13, 2021

“Considering medical appointments, laboratory tests, medications, and indirect costs, juvenile idiopathic arthritis generates elevated costs, which results in a high economic impact for the family,” investigators stated.

Decrease in Pediatric Patient Telemedicine Visits During COVID-19 Pandemic

September 30, 2021

While telemedicine is a valuable tool to provide access to care for families seeking care within a small subspecialty with a limited supply of providers, there was a significantly lower amount of new pediatric patient visits in the beginning of the COVID-19 pandemic.

Majority of Patients With Juvenile Idiopathic Arthritis Achieved Clinical Remission

August 27, 2021

“Juvenile idiopathic arthritis constitutes a significant cause of disability and quality of life impairment in pediatric and adult patients,” investigators stated. “Recent advances in JIA treatment addressing more specific targets have led to better short and long-term disease outcomes."